Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-22

Clinical Trial Update: Clinical Efficacy of Lisdexamfetamine for Methamphetamine Dependence [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the clinical efficacy of lisdexamfetamine for methamphetamine dependence has completed, reporting early signals of efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vyvanse (lisdexamfetamine dimesylate)

Snippet

Sponsor: University of Arkansas | Conditions: Methamphetamine Dependence | Phase 1 | Status: COMPLETED